Back to Search
STEPHEN FRIES, M.D.
M.D.
Pediatrics Physician
NPI: 1770568024Individual
Specialties, Licenses & Credentials
Pediatrics PhysicianPrimary
Pediatrics
Code: 208000000X
23123(CO)
Research & Publications (13)
Novel eicosapentaenoic acid-derived F3-isoprostanes as biomarkers of lipid peroxidation.
PMID 19520854·J Biol Chem·2009
7-preclinical
Cyclooxygenase inhibitors repress vascular hyaluronan-synthesis in murine atherosclerosis and neointimal thickening.
PMID 19320776·J Cell Mol Med·2009
7-preclinical
Characterization of 35 new cases with four different MPLW515 mutations and essential thrombocytosis or primary myelofibrosis.
PMID 19029146·Haematologica·2009
8-other
Tetranor PGDM, an abundant urinary metabolite reflects biosynthesis of prostaglandin D2 in mice and humans.
PMID 17993463·J Biol Chem·2008
7-preclinical
Individual values, learning routines and academic procrastination.
PMID 17971288·Br J Educ Psychol·2007
8-other
Cholesterol delivery to NS0 cells: challenges and solutions in disposable linear low-density polyethylene-based bioreactors.
PMID 17298901·J Biosci Bioeng·2007
7-preclinical
Marked interindividual variability in the response to selective inhibitors of cyclooxygenase-2.
PMID 16401468·Gastroenterology·2006
2-rct
Biological basis for the cardiovascular consequences of COX-2 inhibition: therapeutic challenges and opportunities.
PMID 16395396·J Clin Invest·2006
6-review
The cardiovascular pharmacology of COX-2 inhibition.
PMID 16304418·Hematology Am Soc Hematol Educ Program·2005
7-preclinical
Cyclooxygenases, thromboxane, and atherosclerosis: plaque destabilization by cyclooxygenase-2 inhibition combined with thromboxane receptor antagonism.
PMID 15655126·Circulation·2005
4-observational
COX-2-derived prostacyclin confers atheroprotection on female mice.
PMID 15550624·Science·2004
7-preclinical
Severe pulmonary toxicity in patients with advanced-stage Hodgkin's disease treated with a modified bleomycin, doxorubicin, cyclophosphamide, vincristine, procarbazine, prednisone, and gemcitabine (BEACOPP) regimen is probably related to the combination of gemcitabine and bleomycin: a report of the German Hodgkin's Lymphoma Study Group.
PMID 15136597·J Clin Oncol·2004
3-trial
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 4745 ARAPAHOE AVE., SUITE 200
BOULDER, CO 80303 - Phone
- (303) 938-4750
Quick Facts
- NPI
- 1770568024
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 13
Are you this provider?
Claim Your Profile